Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
F1000Research|August 11, 2016
The expanding regulatory universe of p53 in gastrointestinal cancerAndrew Fesler, Ning Zhang, Jingfang Ju
Oncotarget|March 7, 2018
Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cellsNing Wu, Andrew Fesler, Hua Liu, et al.
Biomarker Research|June 27, 2018
microRNA based prognostic biomarkers in pancreatic CancerShixiang Guo, Andrew Fesler, Huaizhi Wang, et al.
Epigenomics|May 19, 2017
Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancerAndrew Fesler, Shixiang Guo, Hua Liu, et al.
Cancer Translational Medicine|July 28, 2017
Autophagy regulated by miRNAs in colorectal cancer progression and resistanceAndrew Fesler, Hua Liu, Ning Wu, et al.
Biomarker Research|September 17, 2013
Prognostic significance of miR-194 in endometrial cancerHaiyan Zhai, Mihriban Karaayvaz, Peixin Dong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2022
Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeuticsJohn G Yuen, Andrew Fesler, Ga-Ram Hwang, et al.
Oncotarget|August 20, 2015
Identification of miR-215 mediated targets/pathways via translational immunoprecipitation expression analysis (TrIP-chip)Andrew Fesler, Xiao Xu, Xiao Zheng, et al.
Molecular Therapy Oncolytics|March 13, 2023
Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancerGa-Ram Hwang, John G Yuen, Andrew Fesler, et al.
Molecular Therapy. Oncology|April 10, 2024
Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinomaJohn G Yuen, Ga-Ram Hwang, Andrew Fesler, et al.
Pageof 12